# About Oath Research Reviews — Our Editorial Methodology > About Oath Research Reviews — an independent editorial review of one research-peptide supplier. Not affiliated, no commission, no advertising relationships. Methodology grounded in public documentary evidence. An independent editorial review of one research-peptide supplier. The methodology, the boundaries, and the things this site does not do. ## What this site is Oath Research Reviews is an independent editorial review of Oath Research. We are not affiliated with the company we review. We do not sell research peptides, accept advertising from peptide vendors, or receive commission on purchases. We have no financial relationship with Oath Research, Freedom Diagnostics, or any vendor mentioned in our analysis. Our methodology relies on publicly available documentary evidence — lab reports listed in public COA archives, third-party vendor-scoring listings, customer reviews on independent aggregators, regulatory databases (the CMS CLIA registry), pharmacopeia methodology references (United States Pharmacopeia <85>), and forum discourse — combined with editorial judgment. We do not interview the company we review. We do not request products for testing. We do not coordinate the review with the company we review. The independence of the methodology is the foundation of the editorial position. ## How we work Every review on this site follows the same structural pattern. We pull the documentary record (COAs, third-party listings, customer-review aggregator data, regulatory references). We identify what is independently verifiable and what is not. We address negative signal directly — we engage criticism rather than dismiss it. We let the evidence shape the conclusion rather than letting the conclusion shape the selection of evidence. Where the public record is thin or unverifiable, we name the gap; we do not paper over it. The editorial voice is the magazine-feature reviewer — measured, evidence-led, mildly skeptical at the outset, conclusion supported by the documentary record. We do not write promotional copy. We do not use vendor voice. We do not write `we offer` or `our products` because we offer nothing and have no products. The pronoun `we` on this site refers to the publication — it is an editorial we, not an institutional one. ## What this site is not We are not a medical resource. Nothing on this site constitutes medical advice, diagnostic guidance, treatment recommendation, or an offer to sell any compound or preparation. Research peptides are not FDA-approved for human use, and we do not recommend dosing for humans or human application in any form. We are not a clinical service. We are not a vendor. We are not a referral or affiliate property. We are also not the company we review. We do not handle customer service inquiries, refunds, shipping disputes, or product complaints on behalf of the vendor under review. Inquiries about specific orders or product issues must be directed to the vendor through its own channels. The contact form on this site is for editorial correspondence only — corrections, source pointers, and editorial feedback. ## Why we exist The research-peptide market in 2026 carries a verification problem. Trust is hard to establish, and the algorithmic young-domain scoring services that many readers default to (ScamAdviser, Scam-Detector and similar) are calibrated to catch a different class of bad actor — phishing sites, fly-by-night scams, domain-squatter pages — than the question a research-peptide buyer actually faces, which is `"does the testing record stand up, and is the lab who they say it is."` That question requires reading documentary evidence, not running a young-domain heuristic. A second class of confusion has also entered the market: pay-to-rate scoring services that monetize the same vendors they publicly grade, generating ratings whose direction depends on the commercial relationship rather than the testing record. The editorial space for measured independent reading of a single vendor's documentary record, free of either kind of conflict, is the space this publication occupies. --- An outside read of one research-peptide supplier's documentary record — independent, editorial, and not for sale.